Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M

Published on 31 May 2024 on Zacks via Yahoo Finance

Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M

Surmodics, Inc. SRDX announced that it entered a definitive agreement to be acquired by GTCR, a renowned private equity company with extensive experience making investments in the healthcare and technology sectors.

GTCR has its sights on making investments in businesses across several sectors, such as technology and healthcare. It has made more than $25 billion in investments in above 280 firms to date. At the moment, it also oversees $40 billion in equity capital.

Price Performance

Read the rest of the article

NASDAQ.SRDX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up

Surmodics, Inc. SRDX delivered adjusted loss per share of 4 cents in the first quarter of fiscal...

Zacks · via Yahoo Finance 31 Jan 2025

Here's Why You Should Add Surmodics Stock to Your Portfolio Now

Surmodics, Inc. SRDX demonstrated strong performance in the last reported quarter. Its loss per...

Zacks · via Yahoo Finance 23 Jan 2025

Best Momentum Stocks to Buy for January 3rd

Here are two stocks with buy rank and strong momentum characteristics for investors to consider t...

Zacks · via Yahoo Finance 3 Jan 2025

Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M

Surmodics, Inc. SRDX announced that it entered a definitive agreement to be acquired by GTCR, a r...

Zacks via Yahoo Finance 31 May 2024

Minnesota's IPO boom is over, at least for now

The market for going public has cooled, resulting in Minnesota losing more public companies than ...

Minneapolis-St. Paul Star Tribune 30 May 2024

Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In...

Shares of Bank of Montreal BMO fell sharply during Wednesday's session after the company reported...

Benzinga 29 May 2024

Surmodics agrees to $627 million GTCR buyout By Investing.com

Surmodics, Inc. (NASDAQ:SRDX), a significant player in medical device technologies, has reached a...

Investing.com 29 May 2024

Surmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 96% Above Its Share Price

Key Insights The projected fair value for Surmodics is US$68.80 based on 2 Stage Free Cash Flow t...

Simply Wall St. via Yahoo Finance 22 May 2024

Should You Think About Buying Surmodics, Inc. (NASDAQ:SRDX) Now?

Surmodics, Inc. (NASDAQ:SRDX), is not the largest company out there, but it saw significant share...

Simply Wall St. via Yahoo Finance 23 Mar 2024

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Surmodics, Inc. SRDX is well-poised for growth in the coming quarters, courtesy of its solid pros...

Zacks via Yahoo Finance 20 Mar 2024

News

Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M

NASDAQ.SRDX price evolution

Want to become a better investor?